Edison inks pact with Japanese-based DSP for developing orphan mitochondrial … – pharmabiz.com

By Dr. Matthew Watson

Edison inks pact with Japanese-based DSP for developing orphan mitochondrial ...
pharmabiz.com
The positive clinical results of a phase II A trial of EPI - 743 in children with Leigh syndrome were recently reported in Molecular Genetics and Metabolism (EPI - 743 reverses the progression of the paediatric mitochondrial disease — Genetically ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGtpOeKWayL2OgVLR6QcPVbthK2qg&url=http://www.pharmabiz.com/NewsDetails.aspx?aid%3D74525%26sid%3D2



categoriaUncategorized commentoComments Off on Edison inks pact with Japanese-based DSP for developing orphan mitochondrial … – pharmabiz.com | dataMarch 31st, 2013

About...

This author published 5852 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Copyright :: 2024